Tech transfer key to products spun off from CU Boulder, federal labs research

A chance meeting on a Boulder-area trail could lead to a better understanding of particles suspended in the air that have major impacts on weather, climate and air quality. Find out more in the Daily...

Learn More

Innosphere to build new 7,500-square-foot lab space in Fort Collins

In order to keep Colorado companies from relocating out of state because they can’t find a lab, Innosphere is building a new one. Read more in the Denver Business Journal's article about the new life...

Learn More

KromaTiD Announces Launch of dGH SCREEN™ for Unbiased Whole Genome Analysis of Chromosomal Structural Rearrangements

KromaTiD is pleased to announce the launch of dGH Screen™, their new service for mapping the human genome in single cells.  dGH SCREEN™ is built upon KromaTiD’s proprietary directional Genomic Hy...

Learn More

Colorado Springs-area science teacher receives $2,000 STEM grant, intensive biotech training

A Pikes Peak-area science teacher recently received a STEM grant from the Air Force Academy after completing an intensive biotechnology training program that she said will help make classes more inter...

Learn More

LightDeck Diagnostics Strengthens Leadership Team to Spearhead Commercialization of Rapid, Point-of-Care Diagnostics

LightDeck Diagnostics today announced additions to its executive leadership team, naming Russ Peloquin as Chief Commercial Officer and Frank Gill as Chief Product Officer. The two will be joining newl...

Learn More

TriSalus enrolls first patient in pressure-enabled drug delivery trial for treating melanoma

TriSalus Life Sciences announced today that it enrolled the first patient in its clinical study of a treatment for metastatic uveal melanoma. The PERIO-01 clinical study evaluates SD-101, an inve...

Learn More

Boettcher Foundation Stories on Boettcher Investigators, COVID Fund

2021 Boettcher Investigators In late May we announced the names of six leading Colorado researchers who are the newest recipients of grant funding through the Webb-Waring Biomedical Research Awards Pr...

Learn More

Brickell Biotech Expands Leadership Team, Appointing Dr. Monica Luchi as Chief Medical Officer

Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription...

Learn More

Brickell Biotech Acquires Exclusive Rights to Phase 1-Ready DYRK1A Inhibitor Program and Novel Platform Targeting Autoimmune and Inflammatory Diseases

Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription...

Learn More

Cytocom, Inc. Announces Plan to Adopt New Corporate Name “Statera BioPharma, Inc.”

Cytocom, Inc. (Nasdaq: CBLI), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced plans to change its corpor...

Learn More